Remegal Fixed Dose as Adjunctive Therapy in Patients With Partial Seizures

Clinical trial NCT01749046 · COMPLETED

Trial details

NCT number: NCT01749046
Sponsor: Valexfarm
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Epilepsy Simple Partial Seizures Complex Partial Seizures Partial Seizures With Secondary Generalization

Start date: 2012-03-01
Primary completion: 2013-10-01
Enrollment: 224

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.